Status:
COMPLETED
Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
Lead Sponsor:
Allergan
Conditions:
Lateral Canthal Lines
Crow's Feet Lines
Eligibility:
All Genders
18-75 years
Brief Summary
This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.
Eligibility Criteria
Inclusion
- Subject and Investigator decision to treat crow's feet lines with Botox®
Exclusion
- None
Key Trial Info
Start Date :
September 26 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 14 2017
Estimated Enrollment :
667 Patients enrolled
Trial Details
Trial ID
NCT02248844
Start Date
September 26 2014
End Date
August 14 2017
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Robbin Clinic
Gangnam-gu, Seoul, South Korea, 135-839